"Dr. Mink has over 20 years of experience in the development and commercialization of rapid assays and has been instrumental in the development and commercialization of Calypte's rapid tests. Most recently he led the successful effort of setting up the Company's manufacturing in Thailand where we just completed the technology transfer of our blood and oral fluid rapid HIV-1/2 products, and he will lead the China effort in the coming months. Prior to joining Calypte, he was the Director of Research and Development at OraSure Technologies, Inc. (Nasdaq: OSUR). At OraSure, Dr. Mink was the inventor of the first OraQuick HIV-1 rapid prototypes (U.S. Patent 6,303,081), supervised the OraQuick research and development effort and oversaw product transfer to production. Prior experience in the rapid develop arena includes such companies as Eli Lilly and Co. in their diagnostic group and Carter Wallace. Dr. Mink is well suited in this new role."
Nice Info there Sir, much appreciated
Market Data 
Markets 
AI
